AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
Prognostic value of serum biological markers in patients with hepatocellular carcinoma
Authors: Parasole, R Izzo, F Perrone, F Pignata, S Galati, MG Leonardi, E Castiglione, F Orlando, R Castello, G Esposito, G Gallo, C Daniele, B
Citation: R. Parasole et al., Prognostic value of serum biological markers in patients with hepatocellular carcinoma, CLIN CANC R, 7(11), 2001, pp. 3504-3509
Quality of life in lung cancer patients
Authors: Gridelli, C Perrone, F Nelli, F Ramponi, S De Marinis, F
Citation: C. Gridelli et al., Quality of life in lung cancer patients, ANN ONCOL, 12, 2001, pp. S21-S25
Intraluminal HDR brachytherapy in esophageal carcinoma: Ultrasound assisted 3D treatment planning
Authors: Fabrini, MG Gennai, A Perrone, F Rossi, M Lazzeri, M Cionini, L
Citation: Mg. Fabrini et al., Intraluminal HDR brachytherapy in esophageal carcinoma: Ultrasound assisted 3D treatment planning, TUMORI, 87(4), 2001, pp. S103-S103
Activity and toxicity of gemcitabine and gemcitabine plus vinorelbine in advanced non-small-cell lung cancer elderly patients - Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial
Authors: Gridelli, C Cigolari, S Gallo, C Manzione, L Ianniello, GP Frontini, L Ferrau, F Robbiati, SF Adamo, V Gasparini, G Novello, S Perrone, F
Citation: C. Gridelli et al., Activity and toxicity of gemcitabine and gemcitabine plus vinorelbine in advanced non-small-cell lung cancer elderly patients - Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial, LUNG CANC, 31(2-3), 2001, pp. 277-284
Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors
Authors: Birindelli, S Perrone, F Oggionni, M Lavarino, C Pasini, B Vergani, B Ranzani, GN Pierotti, MA Pilotti, S
Citation: S. Birindelli et al., Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors, LAB INV, 81(6), 2001, pp. 833-844
Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial
Authors: Daniele, B Perrone, F Gallo, C Pignata, S De Martino, S De Vivo, R Barletta, E Tambaro, R Abbiati, R D'Agostino, L
Citation: B. Daniele et al., Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial, GUT, 48(1), 2001, pp. 28-33
Carboplatin plus paclitaxel in extensive small cell lung cancer: a multicentre phase 2 study
Authors: Gridelli, C Manzione, L Perrone, F Veltri, E Cioffi, R Caprio, MG Frontini, L Rossi, A Barletta, E Barzelloni, ML Bilancia, D Gallo, C
Citation: C. Gridelli et al., Carboplatin plus paclitaxel in extensive small cell lung cancer: a multicentre phase 2 study, BR J CANC, 84(1), 2001, pp. 38-41
Search for stimulated photon-photon scattering in vacuum
Authors: Bernard, D Moulin, F Amiranoff, F Braun, A Chambaret, JP Darpentigny, G Grillon, G Ranc, S Perrone, F
Citation: D. Bernard et al., Search for stimulated photon-photon scattering in vacuum, EUR PHY J D, 10(1), 2000, pp. 141-145
A phase I study of gemcitabine and epirubicin for the treatment of platinum-resistant or refractory advanced ovarian cancer
Authors: Pignata, S Varriale, E Casella, G Iodice, F De Placido, G Perrone, F Tramontana, F Ricchi, P De Vivo, R Costanzo, R Vernaglia, A Tramontana, S
Citation: S. Pignata et al., A phase I study of gemcitabine and epirubicin for the treatment of platinum-resistant or refractory advanced ovarian cancer, ANN ONCOL, 11(5), 2000, pp. 613-616
Phase I study with weekly cisplatin-paclitaxel and concurrent radiotherapyin patients with carcinoma of the cervix uteri
Authors: Pignata, S Frezza, P Tramontana, S Perrone, F Tambaro, R Casella, G Ferrari, E Iodice, F De Vivo, R Ricchi, P Tramontana, F Silvestro, G
Citation: S. Pignata et al., Phase I study with weekly cisplatin-paclitaxel and concurrent radiotherapyin patients with carcinoma of the cervix uteri, ANN ONCOL, 11(4), 2000, pp. 455-459
Prospective validation of the cancer of the Liver Italian Program (CLIP) score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma - Reply
Authors: Perrone, F Daniele, B Gaeta, GB Pignata, S Gallo, C
Citation: F. Perrone et al., Prospective validation of the cancer of the Liver Italian Program (CLIP) score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma - Reply, HEPATOLOGY, 32(3), 2000, pp. 680-680
Prospective validation of the CLIP score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma
Authors: Perrone, F Daniele, B Gaeta, GB Pignata, S Gallo, C Izzo, F Cuomo, O Capuano, G Ruggiero, G Mazzanti, R Farinati, F Elba, S Daniele, B Pignata, S Cremona, F Izzo, F Parisi, V Fiore, F Vallone, P Perrone, F Cuomo, O Di Palma, M Manno, E Militerno, G Budillon, G Capuano, G Cimino, L Pomponi, D Adinolfi, LE Ragone, E Ruggiero, G Utili, R Arena, U Di Fiore, G Gentilini, P Mazzanti, R Farinati, F Rinaldi, M Elba, S Coviello, A Manghisi, OG Crispino, B Laviscio, R Piaib, G Caporaso, N De Sio, I Belli, G Iannelli, A Santangelo, ML Gaeta, GB Ascione, T Giusti, G D'Angelo, V Francica, G Marone, G Pasquale, G Piccinino, F Stanzione, M Bianco, AR De Placido, S Palmieri, G D'Agostino, L Mattera, D Puzziello, A Aiello, A Ferrau, O Freni, MA Aloisio, V Giorgio, A Perrotta, A Calandra, M Castellano, L Blanco, CD Castiglione, F Mazzacca, G Rispo, A Colurcio, R Galanti, B Russo, M Palmentieri, B Persico, M Felder, M Zancanella, L Belli, M Colantuoni, G De Sena, G Guardascione, F Petrelli, G Lamorgese, B Manzione, L Pedicini, T D'Aprile, M Gallo, C
Citation: F. Perrone et al., Prospective validation of the CLIP score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma, HEPATOLOGY, 31(4), 2000, pp. 840-845
Carboplatin, cisplatin and paclitaxel in the treatment of patients with epithelial ovarian cancer
Authors: De Placido, S Tramontana, S Ferrari, E De Matteis, A Lauria, R Perrone, F Bianco, AR Gallo, C Ricchi, P De Placido, G Pignata, S
Citation: S. De Placido et al., Carboplatin, cisplatin and paclitaxel in the treatment of patients with epithelial ovarian cancer, ANTICANC R, 20(5C), 2000, pp. 4023-4029
Phase I clinical trial of liposomal daunorubicin in hepatocellular carcinoma complicating liver cirrhosis
Authors: Daniele, B De Vivo, R Perrone, F Lastoria, S Tambaro, R Izzo, F Fiore, F Vallone, P Pignata, S
Citation: B. Daniele et al., Phase I clinical trial of liposomal daunorubicin in hepatocellular carcinoma complicating liver cirrhosis, ANTICANC R, 20(2B), 2000, pp. 1249-1251
Intestinal side-effects of docetaxel/vinorelbine combination
Authors: de Matteis, A Nuzzo, F Rossi, E Landi, G Perrone, F
Citation: A. De Matteis et al., Intestinal side-effects of docetaxel/vinorelbine combination, LANCET, 355(9209), 2000, pp. 1098-1099
Vinorelbine plus mitomycin C as second-line treatment of metastatic breastcancer: A two-stage phase 2 study
Authors: De Placido, S Lauria, R Perrone, F Lombardi, AV Carlomagno, C Varriale, E Costanzo, R Leo, L De Laurentiis, M Bianco, AR
Citation: S. De Placido et al., Vinorelbine plus mitomycin C as second-line treatment of metastatic breastcancer: A two-stage phase 2 study, ONCOL-BASEL, 58(1), 2000, pp. 8-14
Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: A randomized, double blind, placebo-controlled trial
Authors: Moghetti, P Tosi, F Tosti, A Negri, C Misciali, C Perrone, F Caputo, M Muggeo, M Castello, R
Citation: P. Moghetti et al., Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: A randomized, double blind, placebo-controlled trial, J CLIN END, 85(1), 2000, pp. 89-94
Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: A randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation
Authors: Moghetti, P Castello, R Negri, C Tosi, F Perrone, F Caputo, M Zanolin, E Muggeo, M
Citation: P. Moghetti et al., Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: A randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation, J CLIN END, 85(1), 2000, pp. 139-146
Intermediate dose recombinant interferon-alpha as second-line treatment for patients with recurrent cutaneous melanoma who were pretreated with low dose interferon
Authors: Ascierto, PA Daponte, A Parasole, R Perrone, F Caraco, C Melucci, MT Palmieri, G Napolitano, M Mozzillo, N Castello, G
Citation: Pa. Ascierto et al., Intermediate dose recombinant interferon-alpha as second-line treatment for patients with recurrent cutaneous melanoma who were pretreated with low dose interferon, CANCER, 89(7), 2000, pp. 1490-1494
Gemcitabine plus vinorelbine in advanced non small cell lung cancer: a phase II study of three different doses
Authors: Gridelli, C Frontini, L Perrone, F Gallo, C Gulisano, M Cigolari, S Castiglione, F Robbiati, SF Gasparini, G Ianniello, GP Farris, A Locatelli, MC Felletti, R Piazza, E
Citation: C. Gridelli et al., Gemcitabine plus vinorelbine in advanced non small cell lung cancer: a phase II study of three different doses, BR J CANC, 83(6), 2000, pp. 707-714
Gastrointestinal symptoms in patients with asthma
Authors: Caffarelli, C Deriu, FM Terzi, V Perrone, F de Angelis, G Atherton, DJ
Citation: C. Caffarelli et al., Gastrointestinal symptoms in patients with asthma, ARCH DIS CH, 82(2), 2000, pp. 131-135
Effects of vinorelbine on quality of life and survival of elderly patientswith advanced non-small-cell lung cancer
Authors: Gridelli, C Perrone, F Gallo, C Rossi, A Scognamiglio, F Monfardini, S Ianniello, GP Tinessa, V Caprio, MG Santoro, A Maiorino, L Santoro, M Brancaccio, L Crispino, C Cigolari, S Di Lanno, M Angelini, V Manzione, L Bilancia, D Dinota, A Failla, G Aiello, RA Tralongo, P Figoli, F Zuccarino, L Pedicini, T Febbraro, A Zollo, C Frontini, L Zonato, S Azzarello, G Vinante, O Castiglione, F Porcile, G Bearz, A Sorio, R Tonato, M Darwish, S Veltri, E D'Aprile, M Curcio, C Vasta, M Clerici, M Luporini, G Farris, A Alicicco, MG Bretti, S Bumma, C Ionta, MT Massidda, B Adamo, V Altavilla, G Stefani, M Michetti, G Iaffaioli, RV Marzano, N Favaretto, A Murtas, S Nascimbene, C Nistico, C Robbiati, SF Strada, MR Belli, M Loizzi, M Bandera, M Bochicchio, AM Piazza, E Foladore, S Giura, R Gualtieri, G Barni, S Cariello, A Mattioli, R Pazzola, A Gioga, G Puxeddu, G Bartolucci, R Graiff, C Del Conte, G Farriniello, GA Mauri, F Corradini, GM Capuano, MA Carrozza, F Gianni, W
Citation: C. Gridelli et al., Effects of vinorelbine on quality of life and survival of elderly patientswith advanced non-small-cell lung cancer, J NAT CANC, 91(1), 1999, pp. 66-72
The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer
Authors: De Placido, S Lauria, R Carlomagno, C Perrone, F De Laurentiis, M Gallo, C Martignetti, A Bellelli, T Limite, G Petrella, G Bianco, AR
Citation: S. De Placido et al., The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer, INT J ONCOL, 15(2), 1999, pp. 339-346
Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix
Authors: Pignata, S Silvestro, G Ferrari, E Selvaggi, L Perrone, F Maffeo, A Frezza, P Di Vagno, G Casella, G Ricchi, P Cormio, G Gallo, C Iodice, F Romeo, F Fiorentino, R Fortuna, G Tramontana, S
Citation: S. Pignata et al., Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix, J CL ONCOL, 17(3), 1999, pp. 756-760
Single-agent gemcitabine as second-line treatment in patients with advanced non small cell lung cancer (NSCLC): a phase II trial
Authors: Gridelli, C Perrone, F Gallo, C Rossi, A Barletta, E Barzelloni, ML Creazzola, S Gatani, T Fiore, F Guida, C Scognamiglio, F
Citation: C. Gridelli et al., Single-agent gemcitabine as second-line treatment in patients with advanced non small cell lung cancer (NSCLC): a phase II trial, ANTICANC R, 19(5C), 1999, pp. 4535-4538
Risultati: 1-25 | 26-30